EOLS
Evolus, Inc.
Key Financials
Operating Income
$-32662000
↑ 5.1%
Revenue
$297.2M
↑ 11.6%
EPS (Diluted)
$-0.80
↑ 1.2%
Total Assets
$225.9M
↓ 2.9%
Shareholders' Equity
$-23106000.00
↓ 518.4%
Total Liabilities
$249.0M
↑ 9.7%
Net Income
$-51641000
↓ 2.4%
Gross Profit
$197.1M
↑ 8.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EOLS |
| Company Name | Evolus, Inc. |
| CIK | 1570562 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (949) 284-4555 |